Su Yahui

Su Yahui has worked in the medical field since 2008. Su began their career as an Assistant Research Scientist at Beijing Cancer Hospital and Institute, where they were responsible for leading the research team conducting two studies of oncology drug candidates. In 2012, they moved to MSD as a Health Science Advisor. In 2013, they became a Clinical Lead at Novartis. In 2015, they were appointed Medical Director at WuXi AppTec China. In 2016, they were promoted to Medical Director at Ascentage Pharma. Finally, in 2020, they were appointed Vice President of Clinical Development at HitGen Inc.

Su Yahui's education history includes a Bachelor's Degree from Peking University, which they obtained from 1998 to 2003 in Medical/Clinical Assistant. Su then went on to obtain a Doctor of Philosophy (Ph.D.) from Peking University in Biochemistry and Molecular Biology, which they completed from 2003 to 2008.